Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
National Institute of Hygiene and Epidemiology, Hanoi 100000, Vietnam.
J Vet Med Sci. 2020 May 20;82(5):653-660. doi: 10.1292/jvms.19-0697. Epub 2020 Mar 30.
Antimicrobial resistance (AMR) is a global public health concern for both clinical and veterinary medicine. Rodent feces are one of the major infectious sources of zoonotic pathogens including AMR bacteria. So far, there are limited studies reported focused on Escherichia coli isolated in rodent feces from rural and suburban areas in Vietnam. In this study, we investigated the prevalence of antimicrobial resistance in E. coli isolated from feces samples of 144 urban rodents caught in Hanoi, Vietnam. A total of 59 AMR E. coli was isolated from urban rodents of which 42 were multidrug-resistant (MDR) isolates (resistance to at least three classes of antimicrobial agents), four were extended-spectrum β-lactamase (ESBL) producing isolates and five were colistin-resistant isolates. The highest prevalence of the resistance was against ampicillin (79.7%: 47/59), followed by tetracycline (78.0%: 46/59), nalidixic acid (67.8%: 40/59), sulfamethoxazole-trimethoprim (59.3%: 35/59), chloramphenicol (45.8%: 27/59), ciprofloxacin (44.1%: 26/59), cefotaxime (30.5%: 18/59), cefodizime (23.7%: 14/59), amoxicillin-clavulanate (22.0%: 13/59), and gentamicin (22.0%: 13/59). With regard to the virulence genes associated with diarrheagenic E. coli (DEC), only aaiC gene found in one AMR isolate. In general, the use of antimicrobials does not aim to treat rodents except for companion animals. However, our findings show the carriage of AMR and MDR E. coli in urban rodents and highlight the potential risk of rodents in Hanoi acting as a reservoir of transferable MDR E. coli, including ESBL-producing, colistin-resistant E. coli, and virulence-associated with DEC.
抗微生物药物耐药性(AMR)是临床和兽医医学领域共同面临的全球公共卫生关注问题。啮齿动物粪便,是包括 AMR 细菌在内的人畜共患病病原体的主要感染源之一。迄今为止,在越南农村和郊区从啮齿动物粪便中分离的大肠杆菌方面,报告的研究有限。在这项研究中,我们调查了从越南河内捕获的 144 只城市啮齿动物粪便样本中分离的大肠杆菌的抗微生物药物耐药性流行情况。从城市啮齿动物中分离出 59 株抗微生物药物耐药性大肠杆菌,其中 42 株为多药耐药(MDR)分离株(对至少三类抗微生物药物耐药),4 株为产超广谱β-内酰胺酶(ESBL)分离株,5 株为黏菌素耐药分离株。耐药率最高的是氨苄西林(79.7%:47/59),其次是四环素(78.0%:46/59)、萘啶酸(67.8%:40/59)、磺胺甲噁唑-甲氧苄啶(59.3%:35/59)、氯霉素(45.8%:27/59)、环丙沙星(44.1%:26/59)、头孢噻肟(30.5%:18/59)、头孢地嗪(23.7%:14/59)、阿莫西林-克拉维酸(22.0%:13/59)和庆大霉素(22.0%:13/59)。关于与腹泻性大肠杆菌(DEC)相关的毒力基因,仅在一株抗微生物药物耐药性分离株中发现 aaiC 基因。一般来说,除了伴侣动物,抗微生物药物的使用并不是为了治疗啮齿动物。然而,我们的研究结果表明,城市啮齿动物携带抗微生物药物耐药性和多重耐药性大肠杆菌,并且突出了河内啮齿动物作为可转移的多重耐药性大肠杆菌(包括产 ESBL、黏菌素耐药的大肠杆菌和与 DEC 相关的毒力)的潜在风险。